Product
BN102
1 clinical trial
2 indications
Indication
Non-Hodgkin lymphomaClinical trial
A Multicenter Phase 1/2 Clinical Study to Evaluate the Safety and Efficacy of BN102 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and B-cell Non-Hodgkin's Lymphoma (NHL)Status: Withdrawn, Estimated PCD: 2024-07-30